Marcela Vargas Trujillo
Pediatric Endocrinology · San Diego, CANPI 1952534091
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by AbbVie at 54.4% of the total. Among pediatric endocrinology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $291.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$31K
- Tolmar, Inc.$13K
- Tolmar Pharmaceuticals, Inc.$10K
- Novo Nordisk$476
- Ferring Pharmaceuticals Inc.$350
- Dexcom, Inc.$327
- plus $2K from 17 others
Across 2 payments — averaging $23,316 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Azurity Pharmaceuticals, Inc.$47K
What the payments were for
- Consulting fees$20,27636%
- Speaking & faculty fees$29,42552%
- Travel & lodging$3,0915%
- Food & beverage$4,0217%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $30,916 |
| Tolmar, Inc. | 16 | $13,358 |
| Tolmar Pharmaceuticals, Inc. | 7 | $9,507 |
| Novo Nordisk | 22 | $476 |
| Ferring Pharmaceuticals Inc. | 14 | $350 |
| Dexcom, Inc. | 15 | $327 |
| Ipsen Biopharmaceuticals, Inc | 9 | $279 |
| Tandem Diabetes Care, Inc. | 10 | $209 |
| BETA Bionics, Inc. | 3 | $196 |
| Insulet Corporation | 8 | $188 |
| Pfizer | 6 | $112 |
| Ascendis Pharma Endocrinology Inc | 4 | $112 |
| Arbor Pharmaceuticals, Inc. | 6 | $102 |
| Eton Pharmaceuticals, Inc. | 1 | $101 |
| Azurity Pharmaceuticals, Inc. | 5 | $97 |
| AstraZeneca | 4 | $93 |
| Medtronic | 5 | $85 |
| Lilly USA, LLC | 4 | $72 |
| Companion Medical, Inc. | 3 | $63 |
| Sandoz | 3 | $59 |
| Kyowa Kirin, Inc. | 2 | $56 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Soleno Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lupron Depot$30,353
- FENSOLVI$22,553
- iLet Bionic Pancreas$406
- iLet Insulin Infusion Kit Inset$135
- iLet Insulin Infusion Kit Contact Detach$135
- Alkindi$101
- KHINDIVI$101
- INCRELEX$101
How this compares
$56,813 in reported general payments places this provider in the 90th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in San Diego
- Karen KleinSan Diego$195K
- Ron NewfieldSan Diego$27K
- Michael GottschalkSan Diego$17K
- Susan PhillipsSan Diego$12K
- Maja MarinkovicSan Diego$5K
- Mary PattersonSan Diego$4K
- Jane KimSan Diego$3K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Francine KaufmanLos Angeles$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.